1.Effect of Vitamin D Status on Von Willebrand Factor and ADAMTS13 in Diabetic Patients on Chronic Hemodialysis.
Keren COHEN-HAGAI ; Gloria RASHID ; Yael EINBINDER ; Meital OHANA ; Sydney BENCHETRIT ; Tali ZITMAN-GAL
Annals of Laboratory Medicine 2017;37(2):155-158
Von Willebrand factor (vWF) is a glycoprotein with a crucial role in the formation of platelet thrombi, and ADAMTS13 is the main enzyme responsible for vWF cleavage. Both are important in the relationship between diabetic nephropathy, hypercoagulability, and cardiovascular disease. This study evaluated a potential relationship between vitamin D (vitD) levels, vWF, ADAMTS13 activity, and inflammation in diabetic patients on chronic hemodialysis (HD). Blood samples from 52 diabetic patients on chronic HD were obtained to determine vitD levels, vWF, and ADAMTS13 activity, and inflammatory markers. HD patients were grouped according to 25-hydroxyvitamin D [25(OH) VitD]<25 nmol/L (n=16) or >25 nmol/L (n=36). vWF antigen and vWF activity were elevated in both groups, with an average of 214.3±82.6% and 175.8±72.6%, respectively. Average ADAMTS13 activity was within the normal range in both groups. Blood samples from the vitD <25 nmol/L group showed a positive correlation between c-reactive protein (CRP) and vWF levels (P=0.023; r=0.564; 95% confidence interval=0.095-0.828), with a negative correlation between HbA1c and 25(OH) VitD (P=0.015; r=-0.337; 95% confidence interval=-0.337-0.19). Diabetic patients on chronic HD had elevated vWF levels and activity with no significant change in ADAMTS13 activity. The correlation between CRP and vWF levels in the 25(OH) VitD<25 nmol/L group suggests inflammatory-related endothelial dysfunction in these patients.
ADAMTS13 Protein/*metabolism
;
Aged
;
C-Reactive Protein/analysis
;
Diabetes Mellitus, Type 2/complications/*diagnosis/metabolism
;
Female
;
Hemoglobin A, Glycosylated/analysis
;
Humans
;
Male
;
Middle Aged
;
Renal Dialysis
;
Renal Insufficiency, Chronic/complications/*diagnosis/metabolism
;
Vitamin D/*analogs & derivatives/blood
;
von Willebrand Factor/*metabolism
2.Tea consumption and risk of biliary tract cancers and gallstone disease: a population-based case-control study in Shanghai, China.
Xue-hong ZHANG ; Yu-tang GAO ; Asif RASHID ; Jie DENG ; En-ju LIU ; Kai WU ; Lu SUN ; Jia-rong CHENG ; Gloria GRIDLEY ; Ann W HSING
Chinese Journal of Oncology 2005;27(11):667-671
OBJECTIVETo investigate the relationship between tea consumption, biliary tract cancers and gallstone disease.
METHODSA population-based case-control study was conducted in urban Shanghai from 1 June 1997 to 31 May 2001 involving interviews with 627 new cases of biliary tract cancers (including 368 cases of gallbladder cancer, 191 cases of extrahepatic bile duct cancer and 68 cases of cancer of the ampulla of Vater) aged 35 to 74 years and 959 population controls frequency-matched to cases by gender and age in five-year group. 1037 patients of gallstone disease were selected from the same hospital. All subjects were interviewed in person by trained interviewers by use of a structured questionnaire. Unconditional logistic regression analysis was used to calculate adjusted odds ratio (OR) and 95% confidence interval (CI).
RESULTSCompared with tea non-drinkers, current tea consumption was inversely associated with risk of gallbladder cancer, extrahepatic bile duct cancer and gallstone disease among females with OR of 0.57 (95% CI: 0.34-0.96), 0.53 (95% CI: 0.27-1.03) and 0.71 (95% CI: 0.51-0.99), respectively. OR declined with younger age at initiation of tea drinking and with longer duration of tea consumption (P for trend < 0.05). Among males, the corresponding OR were mostly below one, although not statistically significant.
CONCLUSIONTea consumption may decrease the risk of cancers of the gallbladder and extrahepatic bile duct among females. The protective effect appears to be independent of gallstone disease.
Adult ; Aged ; Bile Ducts, Extrahepatic ; Biliary Tract Neoplasms ; epidemiology ; etiology ; Case-Control Studies ; China ; epidemiology ; Female ; Flavonoids ; pharmacology ; Gallbladder Neoplasms ; epidemiology ; etiology ; Gallstones ; epidemiology ; etiology ; Humans ; Male ; Middle Aged ; Phenols ; pharmacology ; Polyphenols ; Protective Agents ; pharmacology ; Risk Factors ; Tea ; chemistry
3.Assessing knowledge, acts of discrimination, stigmatizing attitudes and its associated factors towards people living with HIV (PLHIV) among Family Medicine trainees in Malaysia
Hiang Ngee Chan ; Anuar Mohamad ; Aneesa Abdul Rashid ; Bee Kiau Ho ; Alia Abdul Aziz Cooper ; Haslina Mukhtar Aajamer ; Ermi Noor Emjah ; Jashithra Syamala Krishnan ; Gloria Neo Lih Hwee
Malaysian Family Physician 2022;17(3):33-42
Introduction:
Human immunodeficiency virus (HIV)-related stigmatisation and discrimination adversely affect health outcomes in terms of timely diagnosis, treatment and care. Despite global efforts, they remain common among healthcare workers worldwide. In Malaysia, family medicine specialists are entrusted with the care of HIV patients at the primary care level. This study aimed to assess HIV-related knowledge, acts of discrimination, stigmatising attitudes and their associated factors among family medicine trainees in Malaysia.
Methodology:
This cross-sectional study was conducted among 397 family medicine trainees in Malaysia using a validated, self-administered questionnaire that assessed the participants’ sociodemographic information, HIV/AIDS knowledge, stigmatising attitudes (attitudes of blame, attitudes towards imposed measures, comfort in dealing with HIV patients) and acts of discrimination.
Results:
The most common stigmatisation was “attitudes of blame” (mean [SD] score: 3.0 (0.74); range score:1–5), and the most frequent discriminatory act was breaching patient confidentiality (54.9%). Around 82.1% had good knowledge of HIV/AIDS. Married participants and participants who had 7 years or less in service were more stigmatising in “attitudes of imposed measures” towards people living with HIV (p=0.006).
Conclusion
Family medicine trainees exhibited stigmatisation and discrimination towards HIV patients despite having good HIV knowledge. Hence, appropriate and concerted health education should be given to all family medicine trainees to eliminate stigmatisation and discrimination.
Discrimination, Psychological
;
Social Discrimination
;
HIV